What drugs does SEPTODONT make?

SEPTODONT has 8 FDA-approved drugs including DYCLOPRO, PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE.

What therapeutic areas does SEPTODONT focus on?

SEPTODONT focuses primarily on Gastroenterology.

← Back

Data updated: Mar 29, 2026

SEPTODONT

Gastroenterology

Generics

SEPTODONT is a generic drug manufacturer focused on Gastroenterology.

1972

Since

Drugs

Trials

Approved (2yr)

Key Drugs

DYCLOPRO

dyclonine hydrochloride

3 indications · 2018

PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

epinephrine bitartrate

· 2011

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 100%

1 drugs

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

Pfizer big-pharma

Gastroenterology

Bristol-Myers Squibb big-pharma

SEPTODONT

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (8)

Active (4)

Discontinued (4)

Company Info

SEPTODONT

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (8)

Active (4)

Discontinued (4)

Company Info